A CLINICAL STUDY ON ‘RASNADI PANCHDASHAKAM KWATHA’ IN THE MANAGEMENT OF AMAVATA (RHEUMATOID ARTHRITIS)

The disease Amavata can concern the result of a combination of Ama and Vata due to Mandagni. According to the clinical features, Amavata very closely resembles the Rheumatoid Arthritis. According to modern science, Amavata considered an autoimmune condition known as Rheumatoid Arthritis (RA), results in chronic joint inflammation. The prevalence of RA is 0.8% globally. According to a survey of community prevalence, women experience the condition at a 3:1 ratio to men. Without regard of sex, religion and other factors like occupation, a total of 40 individuals with the defining signs and symptoms of Amavata were chosen for this research trial. In the present clinical practice, Rasnadipanchdashakam Kwatha was given orally, 20 ml twice a day for 45 days. Results revealed statistically substantial reductions in Sandhishoola 61.76%, Sandhishotha 42.16%, and Sandhijadyata 49.41%. Additionally, results for Angmarda 52.11%, Aruchi 51.38%, Trishna 51.61%, Alasya 63.01%, Gaurava 50%, Jwara 58.92%, Apaka 59.42%. The overall results of the study were 53.97%.